Addyi Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
31
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$45.6M
Addyi General Information
Description
Operator of a medical company intended for the treatment of female sexual dysfunction. The company offers a drug that helps in the treatment of acquired extremely low libido, enabling pre-menopausal women to reduce distress from the loss of sexual desire and increase the number of satisfying sexual events.
Contact Information
Website
www.addyi.com(Operating Subsidiary)
Corporate Office
- 4350 Lassiter at North Hills Avenue
- Suite 260
- Raleigh, NC 27609
- United States
Corporate Office
- 4350 Lassiter at North Hills Avenue
- Suite 260
- Raleigh, NC 27609
- United States
Addyi Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | 23-Dec-2024 | $45.6M | Completed | Generating Revenue | ||
| 9. Later Stage VC | 04-Sep-2019 | Completed | Generating Revenue | |||
| 8. Seed Round | 04-Jan-2018 | Completed | Generating Revenue | |||
| 7. Merger/Acquisition | 06-Nov-2017 | Completed | Generating Revenue | |||
| 6. Merger/Acquisition | 01-Oct-2015 | Completed | Generating Revenue | |||
| 5. Seed Round | 08-Jun-2015 | Completed | Generating Revenue | |||
| 4. Seed Round | 11-Jul-2014 | Completed | Startup | |||
| 3. Seed Round | 26-Jul-2013 | Completed | Startup | |||
| 2. Seed Round | 11-Jul-2012 | $20M | $25M | Completed | Startup | |
| 1. Seed Round | 21-Mar-2012 | $5M | $5M | Completed | Startup |
Addyi Patents
Addyi Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026146455-A1 | Treatment of sexual desire disorders in patients treated with glp-1 agonists and related agents | Pending | 03-Jan-2025 | ||
| EP-2376457-A2 | Crystalline salt forms of flibanserine | Inactive | 15-Dec-2008 | ||
| CA-2686480-A1 | New salts | Inactive | 15-Dec-2008 | ||
| US-20120322810-A9 | New salts | Inactive | 15-Dec-2008 | ||
| US-20150126524-A1 | Salts | Active | 15-Dec-2008 | C07D235/26 |
Addyi Signals
Addyi Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Auven Therapeutics | PE/Buyout | Minority | ||
| Bausch Health Companies | Corporation | Majority | ||
| Lunsford Capital | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Scientia Ventures | Venture Capital | Minority |
Addyi FAQs
-
When was Addyi founded?
Addyi was founded in 2011.
-
Where is Addyi headquartered?
Addyi is headquartered in Raleigh, NC.
-
What is the size of Addyi?
Addyi has 31 total employees.
-
What industry is Addyi in?
Addyi’s primary industry is Pharmaceuticals.
-
Is Addyi a private or public company?
Addyi is a Private company.
-
What is Addyi’s current revenue?
The current revenue for Addyi is .
-
How much funding has Addyi raised over time?
Addyi has raised $70.1M.
-
Who are Addyi’s investors?
Auven Therapeutics, Bausch Health Companies, Lunsford Capital, , and Scientia Ventures are 5 of 6 investors who have invested in Addyi.
-
When was Addyi acquired?
Addyi was acquired on 23-Dec-2024.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process